384 results on '"Woodhall, Mark"'
Search Results
2. Significance of neuronal autoantibodies in comparison to infectious etiologies among patients presenting with encephalitis in a region with a high prevalence of infections
3. Timing of MOG-IgG Testing Is Key to 2023 MOGAD Diagnostic Criteria
4. Peripheral VH4+ plasmablasts demonstrate autoreactive B cell expansion toward brain antigens in early multiple sclerosis patients
5. Comparison of N-methyl-d-aspartate receptor antibody assays using live or fixed substrates
6. Detection of MOG-IgG by cell-based assay: moving from discovery to clinical practice
7. The clinical profile of NMOSD in Australia and New Zealand
8. Do Early Relapses Predict the Risk of Long‐Term Relapsing Disease in an Adult and Paediatric Cohort with MOGAD?
9. Iron transport and storage in Escherichia coli
10. International multicenter examination of MOG antibody assays
11. SHP2 inhibitor protects AChRs from effects of myasthenia gravis MuSK antibody
12. Classifying the antibody-negative NMO syndromes: Clinical, imaging, and metabolomic modeling
13. Antibodies Produced by CLL Phenotype B Cells in Patients With Myasthenia Gravis Are Not Directed Against Neuromuscular Endplates
14. Neuromyelitis optica relapses: Race and rate, immunosuppression and impairment
15. A multicenter comparison of MOG-IgG cell-based assays
16. Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies
17. Clinical pitfalls and serological diagnostics of MuSK myasthenia gravis
18. 067 One Health: Clinical characteristics of spontaneously-arising feline LGI1- autoantibody limbic encephalitis in a large international cohort
19. 130 IgLON5-antibody disease: a case series
20. Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis
21. Complement activation in patients with neuromyelitis optica
22. Serological and experimental studies in different forms of myasthenia gravis
23. Seizures and Encephalitis in Myelin Oligodendrocyte Glycoprotein IgG Disease vs Aquaporin 4 IgG Disease
24. PO154 A comparison of nmdar-antibody detection methods
25. PO147 Myelin oligodendrocyte glycoprotein-antibody disease in the uk
26. PO133 Neuromyelitis optica spectrum disease preceded by three year history of intermittent gastro-intestinal dysfunction
27. Clinical presentation and prognosis in MOG-antibody disease: a UK study
28. Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases
29. Rituximab abrogates aquaporin-4–specific germinal center activity in patients with neuromyelitis optica spectrum disorders
30. Serum MOG-IgG in children meeting multiple sclerosis diagnostic criteria
31. Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis
32. Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease
33. Chronic neuropathic pain severity is determined by lesion level in aquaporin 4-antibody-positive myelitis
34. Fixed myelin oligodendrocyte glycoprotein (MOG) autoantibody cell-based assays (CBA): A cautionary tale
35. Response to treatment in NMOSD: the Australasian experience
36. Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease in the United Kingdom
37. Utility of Live Cell-Based Assays for Autoimmune Neurology Diagnostics
38. Predictors of relapse in MOG antibody associated disease: a cohort study
39. MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis
40. Frequency of MOG-IgG in cerebrospinal fluid versus serum
41. Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis
42. Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features
43. MRI Patterns Distinguish Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis (4128)
44. Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes
45. Autoantibody biomarkers in childhood-acquired demyelinating syndromes: results from a national surveillance cohort
46. Investigation of neuronal autoantibodies in two different focal epilepsy syndromes
47. Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies: A Comparative Study
48. Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive Patients in a Multi-Ethnic Canadian Cohort
49. Longitudinally Extensive Transverse Myelitis With and Without Aquaporin 4 Antibodies
50. Thermodynamic analysis of ferrous ion binding to Escherichia coli ferritin EcFtnA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.